Back to Journals » Breast Cancer: Targets and Therapy » Volume 10

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Total article views   Abstract views HTML views PDF downloads Totals
5,064 Dovepress* 4,234 487+ 723 4,721
PubMed Central* 0 343 84 343
Totals 4,234 830 807 5,064
*Since 22 March 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
40 1 0 0 7 32

View citations on PubMed Central and Google Scholar